Coronavirus Disease 2019 in patients with renal diseases

ABSTRACT

The whole world has been frightened because of the rapid rise in the number of cases and deaths due to novel coronavirus (officially referred to as coronavirus disease 2019 [COVID-19]) which was found in late 2019 in Wuhan city, China. Till date, the increased spread of novel coronavirus disease (COVID-19) is even now at an uncontrollable rate, and the amount of confirmed patients and mortality rate are still increasing at an exponential rate. Till October 1, 2020, from 216 different nations, regions, and territories, the World Health Organization received reports of 33,842,282 confirmed cases and 1,010,635 confirmed deaths. This virus causes a variety of symptoms which can range from mild illness to moderate illness. Difficulty in breathing and death occur in severe cases. The common earliest manifestations include fever, cough, fatigue, myalgia, diarrhea, and headaches. The disease is mainly transmitted through respiratory droplets from a person who is infected, via coughing, sneezing, or exhaling. Adding together expertize across various domains to search for new and effective solutions is the need of hour. Very little is known about how coronavirus affects the kidneys. There is no such proof that shows if people with renal diseases are more susceptible than the general public. Studies have been made over complications of coronavirus disease in patients with renal diseases and how to tackle them. This review article summarizes the analysis of the present situation with subject to coronavirus pandemic, its sequel on people with renal disorders, and the seriousness of the disease. Majorly, it gives an outline in management of this critical condition. © 2022 Wolters Kluwer Medknow Publications. All rights reserved.